Interview with
Brighter´s advisor.

MD Jorge C. Otero visited us in Stockholm and we took the opportunity to interview him. See the video where he explains how connected tools can be helpful in clinical trials and empower the patients. Jorge is Brighter´s new expert advisor in clinical development and medical affairs. He is based in the US and has an extensive and documented background from large pharmaceutical companies. Together with the company’s management Jorge will develop the go to market strategies for Actiste and evaluate additional business areas in which the product can be applied, in addition to diabetes. Read the press release here.


Jorge Otero

Jorge is a Medical Oncologist and an expert within medical affairs and strategic clinical development. He has a global experience from the pharmaceutical industry as Amgen, GlaxoSmithKline and Eli Lilly. With his proven skills as a business leader and experience from different executive positions within clinical development, medical affairs and related areas, his contribution is of highest value to Brighter. He has deep knowledge within oncology and clinical research as well as execution of novel medical affairs projects.

Michael Alvarsson

Ass. Prof. Michael Alvarsson, chief physician at Karolinska University Hospital in Solna, is active at the Clinic of Endocrinology, Metabolism and Diabetes. He also conducts clinical diabetes research at the Department of Molecular medicine and Surgery (MMK) at Karolinska Institute. The cooperation entails that Brighter further strengthens its competence regarding practical diabetes treatment and research within endocrinology.

Gösta Sjöholm

Honorary Coach at STING with long industrial experience, particularly in the medical field. He has worked with development, manufacturing, clinical evaluation of devices and products for drug discovery. Gösta has extensive experience from large international corporations as well as start-up companies.

Lars Wibell

Associate Professor Lars Wibell at Uppsala University Hopsital, is one of Sweden’s best-known scientists in the area of diabetes. He is an enthusiastic champion of good blood glucose level control, catering insulin treatment to each patient, and introduced HbA1c analysis in Sweden. Lars is one of the people who made significant contributions in the early days and continues in the same vein.

Olof Berglund

Business Coach at STING. MBA with specialization in marketing and organization. 20 years of experience in pharmaceutical and medtech industry as salesman, sales manager, product manager, marketing manager, commercial director, marketing director and CEO.

Peter Thomsen

Peter Thomsen has the right business background for the company. He is a strategy consultant at Capgemini Consulting and contributed in the development of the global marketing strategy for Novo Nordisk – the world’s leading insulin producer.